Medical Oddities: An Overlooked Existential Flight Risk
-
By
-
Teraya Smith
-
January 7, 2026
-
4 min
By
Teraya Smith
January 7, 2026
Protection against spread appeared strongest within 6 months of vaccination, while exposed vaccinated contacts showed no measurable reduction in infection risk.
by Kerri Miller
May 18, 2026
A phase 2 randomized trial suggests reducing nasal commensal viruses with ribavirin spray may improve allergic rhinitis symptoms while supporting a proposed disease mechanism.
July 7, 2026
BALANCE compared 7 vs 14 days of treatment among hospitalized patients with bloodstream infections.
May 12, 2026